Reversible posterior leukoencephalopathy syndrome and bevacizumab in breast cancer.
St Vincent's University Hospital, Dublin, Ireland.
Francesco
F
Sclafani
Gullo
G
Giuseppe
Janusz
J
Mezynksi
Conor
C
Collins
John
J
Crown
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced*
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab